Filing Details
- Accession Number:
- 0001104659-19-002500
- Form Type:
- 13G Filing
- Publication Date:
- 2019-01-18 16:12:41
- Filed By:
- Inspirational Visions B.v.
- Company:
- Proqr Therapeutics N.v. (NASDAQ:PRQR)
- Filing Date:
- 2019-01-18
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Stichting Aescap | 1,439,815 | 0 | 1,439,815 | 0 | 1,439,815 | 3.7% |
Privium Fund Management B.V | 1,439,815 | 0 | 1,439,815 | 0 | 1,439,815 | 3.7% |
Inspirational Visions BV | 18,411 | 0 | 18,411 | 0 | 18,411 | 0.1% |
Patrick Johan Hendrik Krol | 1,458,226 | 0 | 1,458,226 | 0 | 1,458,226 | 3.8% |
| UNITED STATES |
|
| SECURITIES AND EXCHANGE COMMISSION |
|
| Washington, D.C. 20549 |
|
|
|
|
SCHEDULE 13G
Under the Securities Exchange Act of 19341
(Amendment No. 1)*
ProQR Therapeutics N.V.
(Name of Issuer)
Ordinary Shares, nominal value 0.04 per share
(Title of Class of Securities)
N71542109
(CUSIP Number)
December 31, 2018
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o | Rule 13d-1(b) |
x | Rule 13d-1(c) |
o | Rule 13d-1(d) |
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. N71542109 | |||||
| |||||
| 1 | Name of Reporting Persons | |||
| |||||
| 2 | Check the Appropriate Box if a Member of a Group | |||
|
| (a) | o | ||
|
| (b) | o | ||
| |||||
| 3 | SEC Use Only | |||
| |||||
| 4 | Citizenship or Place of Organization | |||
|
|
| |||
Number of | 5 | Sole Voting Power | |||
| |||||
6 | Shared Voting Power | ||||
| |||||
7 | Sole Dispositive Power | ||||
| |||||
8 | Shared Dispositive Power | ||||
| |||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o | |||
| |||||
| 11 | Percent of Class Represented by Amount in Row (9) | |||
| |||||
| 12 | Type of Reporting Person (See Instructions) | |||
(1) Based upon 38,715,563 ordinary shares outstanding as of September 30, 2018, as disclosed in the Issuers Registration Statement on Form F-3 filed on November 7, 2018.
2
| 1 | Name of Reporting Persons | |||
| |||||
| 2 | Check the Appropriate Box if a Member of a Group | |||
|
| (a) | o | ||
|
| (b) | o | ||
| |||||
| 3 | SEC Use Only | |||
| |||||
| 4 | Citizenship or Place of Organization | |||
|
|
| |||
Number of | 5 | Sole Voting Power | |||
| |||||
6 | Shared Voting Power | ||||
| |||||
7 | Sole Dispositive Power | ||||
| |||||
8 | Shared Dispositive Power | ||||
| |||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o | |||
| |||||
| 11 | Percent of Class Represented by Amount in Row (9) | |||
| |||||
| 12 | Type of Reporting Person (See Instructions) | |||
(1) Based upon 38,715,563 ordinary shares outstanding as of September 30, 2018, as disclosed in the Issuers Registration Statement on Form F-3 filed on November 7, 2018.
3
CUSIP No. N71542109 | |||||
| |||||
| 1 | Name of Reporting Persons | |||
| |||||
| 2 | Check the Appropriate Box if a Member of a Group | |||
|
| (a) | o | ||
|
| (b) | o | ||
| |||||
| 3 | SEC Use Only | |||
| |||||
| 4 | Citizenship or Place of Organization | |||
|
|
| |||
Number of | 5 | Sole Voting Power | |||
| |||||
6 | Shared Voting Power | ||||
| |||||
7 | Sole Dispositive Power | ||||
| |||||
8 | Shared Dispositive Power | ||||
| |||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o | |||
| |||||
| 11 | Percent of Class Represented by Amount in Row (9) | |||
| |||||
| 12 | Type of Reporting Person (See Instructions) | |||
(1) Based upon 38,715,563 ordinary shares outstanding as of September 30, 2018, as disclosed in the Issuers Registration Statement on Form F-3 filed on November 7, 2018.
4
| 1 | Name of Reporting Persons | |||
| |||||
| 2 | Check the Appropriate Box if a Member of a Group | |||
|
| (a) | o | ||
|
| (b) | o | ||
| |||||
| 3 | SEC Use Only | |||
| |||||
| 4 | Citizenship or Place of Organization | |||
|
|
| |||
Number of | 5 | Sole Voting Power | |||
| |||||
6 | Shared Voting Power | ||||
| |||||
7 | Sole Dispositive Power | ||||
| |||||
8 | Shared Dispositive Power | ||||
| |||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o | |||
| |||||
| 11 | Percent of Class Represented by Amount in Row (9) | |||
| |||||
| 12 | Type of Reporting Person (See Instructions) | |||
(1) Based upon 38,715,563 ordinary shares outstanding as of September 30, 2018, as disclosed in the Issuers Registration Statement on Form F-3 filed on November 7, 2018.
5
Item 1. | (a). | Name of Issuer |
|
| ProQR Therapeutics N.V. (the Issuer) |
|
| |
| (b). | Address of Issuers Principal Executive Offices: |
|
| Zernikedreef 9, 2333 CK Leiden, The Netherlands |
|
| |
Item 2(a). | Name of Person Filing Address of Principal Business Office Citizenship
(i) Stichting Aescap 2.0 (Aescap 2.0) Gustav Mahlerplein 3 1082 MS Amsterdam The Netherlands Citizenship: The Netherlands
(ii) Privium Fund Management B.V. (Privium), as the fund manager of Aescap 2.0 Gustav Mahlerplein 3 1082 MS Amsterdam The Netherlands Citizenship: The Netherlands
(iii) Inspirational Visions BV (Inspirational Visions) Science Park 406 1098XH Amsterdam The Netherlands Citizenship: The Netherlands
(iv) Patrick Johan Hendrik Krol (Krol), the portfolio manager for Privium and the managing director of Inspirational Visions Gustav Mahlerplein 3 1082 MS Amsterdam The Netherlands Citizenship: The Netherlands
The foregoing persons are hereinafter sometimes collectively referred to as the Reporting Persons. | |
|
| |
Item 2(d). | Title of Class of Securities:
Ordinary Shares, nominal value 0.04 per share (the Shares) | |
|
| |
Item 2(e). | CUSIP Number:
N71542109 |
6
Item 3. | If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
This Item 3 is not applicable. | |||
|
| |||
Item 4. | Ownership. | |||
|
|
| ||
| (a) | Amount beneficially owned: | ||
|
|
| ||
|
| As of December 31, 2018, Aescap 2.0 directly held 1,439,815 Shares. | ||
|
|
| ||
|
| As of December 31, 2018, Privium may be deemed to beneficially own the 1,439,815 Shares held by Aescap 2.0. | ||
|
|
| ||
|
| As of December 31, 2018, Inspirational Visions directly held 18,411 Shares. | ||
|
|
| ||
|
| As of December 31, 2018, as the portfolio manager of Privium, Krol may be deemed to beneficially own the 1,439,815 Shares held by Aescap 2.0. In addition, as of December 31, 2018, as the managing director of Inspirational Visions, Krol may be deemed to beneficially own the 18,411 Shares held by Inspirational Visions. | ||
|
|
| ||
| (b) | Percent of class: | ||
|
|
| ||
|
| As of December 31, 2018, Aescap 2.0 may be deemed the beneficial owner of approximately 3.7% of the Shares outstanding.. | ||
|
|
| ||
|
| As of December 31, 2018, Privium may be deemed the beneficial owner of approximately 3.7% of the Shares outstanding. | ||
|
|
| ||
|
| As of December 31, 2018, Inspirational Visions may be deemed the beneficial owner of 0.1% of the Shares outstanding. | ||
|
|
| ||
|
| As of December 31, 2018, Krol may be deemed the beneficial owner of approximately 3.8% of the Shares outstanding. | ||
|
|
| ||
| (c) | Number of Shares as to which the Reporting Person has: | ||
|
|
| ||
| Aescap 2.0: | |||
|
| |||
| (i) | Sole power to vote or to direct the vote:
1,439,815 | ||
| (ii) | Shared power to vote or to direct the vote:
0 | ||
| (iii) | Sole power to dispose or to direct the disposition of:
1,439,815 | ||
| (iv) | Shared power to dispose or to direct the disposition of:
0 | ||
|
| |||
| Privium: | |||
|
| |||
| (i) | Sole power to vote or to direct the vote:
1,439,815 | ||
| (ii) | Shared power to vote or to direct the vote:
0 | ||
| (iii) | Sole power to dispose or to direct the disposition of:
1,439,815 | ||
| (iv) | Shared power to dispose or to direct the disposition of:
0 | ||
|
| |||
| Inspirational Visions: | |||
|
| |||
| (i) | Sole power to vote or to direct the vote:
18,411 | ||
| (ii) | Shared power to vote or to direct the vote:
0 | ||
| (iii) | Sole power to dispose or to direct the disposition of:
18,411 | ||
| (iv) | Shared power to dispose or to direct the disposition of:
0 | ||
|
| |||
| Kroll: | |||
|
| |||
| (i) | Sole power to vote or to direct the vote:
1,458,226 | ||
| (ii) | Shared power to vote or to direct the vote:
0 | ||
| (iii) | Sole power to dispose or to direct the disposition of:
1,458,226 | ||
| (iv) | Shared power to dispose or to direct the disposition of:
0 | ||
7
Item 5. | Ownership of Five Percent or Less of a Class
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:x. | |
|
|
Item 6. | Ownership of More than Five Percent on Behalf of Another Person.
This Item 6 is not applicable. |
|
|
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
This Item 7 is not applicable. |
|
|
Item 8. | Identification and Classification of Members of the Group.
This Item 8 is not applicable. |
|
|
Item 9. | Notice of Dissolution of Group.
This Item 9 is not applicable. |
|
|
Item 10. | Certification.
Each of the Reporting Persons hereby makes the following certification:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |
8
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
STICHTING AESCAP 2.0 | ||
| ||
BY: PRIVIUM FUND MANAGEMENT B.V., ITS FUND MANAGER | ||
| ||
By: | /s/ Patrick Johan Hendrik Krol |
|
Name: | P.J.H. Krol |
|
Title: | Portfolio Manager |
|
|
|
|
PRIVIUM FUND MANAGEMENT B.V. |
| |
|
|
|
By: | /s/ Patrick Johan Hendrik Krol |
|
Name: | P.J.H. Krol |
|
Title: | Portfolio Manager |
|
|
|
|
INSPIRATIONAL VISIONS B.V. |
| |
|
|
|
By: | /s/ Patrick Johan Hendrik Krol |
|
Name: | P.J.H. Krol |
|
Title: | Managing Director |
|
|
|
|
PATRICK JOHAN HENDRIK KROL |
| |
|
|
|
| /s/ Patrick Johan Hendrik Krol |
|
Dated: January 18, 2019
9